Seelos Therapeutics, Inc. Current Liabilities
Seelos Therapeutics, Inc. had Current Liabilities of $30.51 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2024-08-14
- 2024-06-30: Liabilities, Current $30.51M.
- 2024-03-31: Liabilities, Current $36.72M.
- 2023-12-31: Liabilities, Current $38.93M.
- 2023-09-30: Liabilities, Current $35.33M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2024-06-30 | $30.51M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $36.72M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $38.93M 10-Q · filed 2024-08-14 | |
| 2023-09-30 | $35.33M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $56.11M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $39.20M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $25.16M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $21.89M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $14.63M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $10.13M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $8.29M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $8.03M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $7.59M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $13.34M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $7.43M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.71M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $7.21M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.78M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $5.54M 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $4.90M 10-K · filed 2020-03-17 | $1.17M 10-K · filed 2019-03-28 |
| 2018-09-30 | $1.43M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $1.90M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.69M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.58M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $1.81M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.84M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $2.59M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $11.29M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $12.61M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $13.27M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $13.25M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $15.68M 10-K · filed 2017-03-13 | $15.76M 10-K · filed 2016-03-09 |
| 2015-09-30 | $6.86M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $4.97M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $7.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.91M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $6.39M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $6.97M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $14.58M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $11.76M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $8.40M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $11.00M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $10.17M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $10.77M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $14.78M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $10.87M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $9.89M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $10.02M 10-K · filed 2013-03-18 | $10.02M 10-K · filed 2012-03-13 |
| 2011-09-30 | $2.89M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.68M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $2.32M 10-K · filed 2012-03-13 |